Nu Skin Enterprises (NUS) Reports In-Line Q1 EPS, Revenues Beat; Affirms FY19 EPS/Revenue Mid-Point Guidance Above Consensus, Provides 2Q EPS/Revenue Outlook

Go back to Nu Skin Enterprises (NUS) Reports In-Line Q1 EPS, Revenues Beat; Affirms FY19 EPS/Revenue Mid-Point Guidance Above Consensus, Provides 2Q EPS/Revenue Outlook
NUSKIN ENTERPRISES, Inc. (NYSE: NUS) Delayed: 5.02 --0 (-0%)
Previous Close $5.02    52 Week High $66.04 
Open $5.02    52 Week Low $23.51 
Day High $5.02    P/E 1.03 
Day Low $5.02    EPS $4.89 
Volume 30